Predicate |
Object |
contentType |
Journal Article |
endingPage |
2 |
issn |
1523-2859 |
issueIdentifier |
1297 |
pageRange |
81-2 |
publicationName |
The Medical letter on drugs and therapeutics |
startingPage |
81 |
bibliographicCitation |
Certolizumab (Cimzia) for Crohn's disease. Med Lett Drugs Ther. 2008 Oct 20;50(1297):81–2. PMID: 18927521. |
date |
2008-10-20^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/18927521 |
isPartOf |
https://portal.issn.org/resource/ISSN/1523-2859 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5635 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
Certolizumab (Cimzia) for Crohn's disease |
discusses |
http://id.nlm.nih.gov/mesh/M0017182 http://id.nlm.nih.gov/mesh/M0009027 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0507051 http://id.nlm.nih.gov/mesh/M0022150 http://id.nlm.nih.gov/mesh/M0001333 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D007140Q000627 http://id.nlm.nih.gov/mesh/D005765Q000627 http://id.nlm.nih.gov/mesh/D011092Q000627 http://id.nlm.nih.gov/mesh/D000893Q000627 http://id.nlm.nih.gov/mesh/D003424Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D007140Q000009 http://id.nlm.nih.gov/mesh/D000068582 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011092Q000008 http://id.nlm.nih.gov/mesh/D005765Q000009 http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D005765Q000008 http://id.nlm.nih.gov/mesh/D000893Q000008 http://id.nlm.nih.gov/mesh/D014409Q000037 http://id.nlm.nih.gov/mesh/D000893Q000009 http://id.nlm.nih.gov/mesh/D003424Q000276 http://id.nlm.nih.gov/mesh/D007140Q000008 http://id.nlm.nih.gov/mesh/D011092Q000009 |